VIR BIOTECHNOLOGY H-1B Visa Sponsorship & Salary Data

The median H-1B salary at VIR BIOTECHNOLOGY is $135,000, based on 60 certified filings from FY 2020 to FY 2025. This is 13% higher than the national H-1B median salary of $120,000. Compensation at VIR BIOTECHNOLOGY reflects their market positioning, with entry-level roles starting around $113,000 and senior positions reaching $200,285 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at VIR BIOTECHNOLOGY range from $93,921 at the 10th percentile to $200,285 at the 90th percentile, showing a $106,364 spread across experience levels and roles. The 25th percentile is $113,000 and the 75th percentile is $180,000.

Yes, VIR BIOTECHNOLOGY actively sponsors H-1B visas in FY 2025. In the most recent fiscal year (FY 2025), VIR BIOTECHNOLOGY filed 7 H-1B labor condition applications with 7 certified and 0 denied, at a median salary of $180,000. Across FY 2020–2025, they have filed 60 total H-1B applications with 60 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. VIR BIOTECHNOLOGY sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), VIR BIOTECHNOLOGY filed 7 H-1B applications, with 7 certified and 0 denied. Over 6 years of data, VIR BIOTECHNOLOGY has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

VIR BIOTECHNOLOGY's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 60 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating VIR BIOTECHNOLOGY as a potential H-1B sponsor.

This is an excellent approval rate, indicating VIR BIOTECHNOLOGY has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

VIR BIOTECHNOLOGY sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 60 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles VIR BIOTECHNOLOGY most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at VIR BIOTECHNOLOGY:

The most frequently sponsored role is Research Scientist with 19 filings at a median salary of $125,000. This is followed by Research Associate II (5 filings) and Senior Research Associate.

VIR BIOTECHNOLOGY's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where VIR BIOTECHNOLOGY sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top VIR BIOTECHNOLOGY H-1B locations:

The largest H-1B hub for VIR BIOTECHNOLOGY is San Francisco, CA with 38 filings at a median salary of $132,500. The highest-paying location is Allen, TX at $202,754 median. Salaries range from $100,000 to $202,754 across office locations.

VIR BIOTECHNOLOGY's median H-1B salary has increased by +20% from FY 2020 ($150,000) to FY 2025 ($180,000). Tracking salary trends over time reveals how VIR BIOTECHNOLOGY adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at VIR BIOTECHNOLOGY.

Year-by-year breakdown:

• FY 2021: $130,000 (14 certified)
• FY 2022: $154,041 (10 certified)
• FY 2023: $125,000 (17 certified)
• FY 2024: $196,823 (6 certified)
• FY 2025: $180,000 (7 certified)

VIR BIOTECHNOLOGY has maintained steady salary growth for H-1B positions over this period.

VIR BIOTECHNOLOGY primarily files H-1B applications at Wage Level I, accounting for 35% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making VIR BIOTECHNOLOGY's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

VIR BIOTECHNOLOGY has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

VIR BIOTECHNOLOGY's median H-1B salary of $135,000 is 13% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating VIR BIOTECHNOLOGY's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare VIR BIOTECHNOLOGY's offerings with similar companies in your field for a more accurate assessment.

VIR BIOTECHNOLOGY offers above-average H-1B compensation. Combined with their 60 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. VIR BIOTECHNOLOGY files 35% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 60 certified filings, VIR BIOTECHNOLOGY invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.